早期乳腺癌辅助放疗患者参与随机临床试验保留率的社会经济障碍
该研究对一项常规分割与大分割全乳照射随机3期试验中的253例患者进行二次分析,以3年随访时完成乳房美容评估定义试验保留。3年脱落率21.7%,5年脱落率36.7%。社会经济剥夺程度较高(ADI≥45)与3年(OR 3.63)和5年(OR 2.55)脱落相关。
要点
- 3年随访时21.7%患者脱落,5年随访时36.7%患者脱落。
- ADI≥45与3年脱落相关(OR 3.63,95%CI 1.62-8.15,P=.002)。
- ADI≥45与5年脱落相关(OR 2.55,95%CI 1.37-4.76,P=.003)。
核心结论
- 在本研究中,ADI与接受辅助放疗的乳腺癌患者在临床试验保留方面的差异相关。
- 结果提示需要制定超越常规社会决定因素筛查的多维度干预措施,不仅增强初始临床试验可及性和入组,还能使社会经济弱势患者实现稳健的长期保留,并提高所报告的长期试验临床和患者报告结局的有效性和普遍性。
研究设计与样本
- 对一项常规分割与大分割全乳照射随机3期试验中入组的287例患者中的253例进行二次分析。
- 主要结局为试验保留 versus 脱落,主要基于患者是否在3年随访时完成乳房美容结局评估,次要基于5年随访。
- 使用Kruskal-Wallis检验和多变量逻辑回归检验保留与ADI等级(1[最不剥夺]至100[最剥夺])所量化的社会经济剥夺严重程度之间的关联。
- 使用χ2检验分析保留与患者使用社会资源援助之间的关联。
主要发现
- 总计21.7%(n=55)患者在3年时脱落,36.7%(n=92)在5年时脱落。
- 保留患者的中位ADI为36.5(四分位距22-57),脱落患者为46.0(四分位距29-60)。
- 脱落与更严重的社会经济剥夺(ADI≥45 vs <45)在3年时相关(比值比3.63;95%置信区间1.62-8.15;P=.002),在5年时相关(比值比2.55;95%置信区间1.37-4.76;P=.003)。
- 在研究期间,最终脱落的患者更可能需要实际需求(交通、住房、经济)方面的资源援助,而非心理需求(痛苦、悲伤)或预先护理计划(P=.03)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Socioeconomic barriers contribute to breast cancer clinical trial enrollment disparities. We sought to identify whether socioeconomic disadvantage also is associated with decreased trial retention. METHODS AND MATERIALS: We performed a secondary analysis of 253 (of 287) patients enrolled in a randomized phase 3 trial of conventionally fractionated versus hypofractionated whole-breast irradiation. The outcome of trial retention versus dropout was defined primarily based on whether the patient completed breast cosmesis outcomes assessment at 3-year follow-up, and secondarily, at 5-year follow-up. Associations of retention with severity of socioeconomic disadvantage, quantified by patients' home neighborhood area deprivation index (ADI) rank (1 [least] to 100 [most deprivation]), were tested using the Kruskal-Wallis test and multivariate logistic regression. Associations of retention with patients' use of social resource assistance were analyzed using the χ2 test. RESULTS: In total, 21.7% (n = 55) of patients dropped out by 3 years and 36.7% (n = 92) by 5 years. Median ADI was 36.5 (interquartile range, 22-57) for retained and 46.0 (interquartile range, 29-60) for dropout patients. Dropout was associated with more severe socioeconomic deprivation (ADI ≥45 vs <45) at 3 years (odds ratio, 3.63; 95% confidence interval, 1.62-8.15; P = .002) and 5 years (odds ratio, 2.55; 95% confidence interval, 1.37-4.76; P = .003). While on study, patients who ultimately dropped out were more likely to require resource assistance for practical (transportation, housing, financial) than psychological needs (distress, grief) or advance care planning (P = .03). CONCLUSIONS: In this study, ADI was associated with disparities in clinical trial retention of patients with breast cancer receiving adjuvant radiation treatment. Results suggest that developing multidimensional interventions that extend beyond routine social determinants needs screening are needed, not only to enhance initial clinical trial access and enrollment but also to enable robust long-term retention of socioeconomically disadvantaged patients and improve the validity and generalizability of reported long-term trial clinical and patient-reported outcomes.
引用
- Shi JJ, Lei X, Chen YS, et al. Socioeconomic Barriers to Randomized Clinical Trial Retention in Patients Treated With Adjuvant Radiation for Early-Stage Breast Cancer. Int J Radiat Oncol Biol Phys. 2023. PMID: 36724858. doi:10.1016/j.ijrobp.2023.01.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。